COVID-19 Funding Opportunities
The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.
Application Deadline: 5:00 pm Monday, December 7
The milestone-driven Accelerated Translational Incubator Pilot (ATIP) program provides up to $100,000 over twelve months in targeted funding and project management for faculty conducting translational research projects. The ICTR is now requesting applications with a submission deadline of 5:00 PM on Monday, December 7, 2020. Johns Hopkins University faculty members interested in obtaining funding for a new or ongoing translational project should see the RFA for further details and eligibility information.
Briefly, proposals submitted for consideration
must satisfy the following requirements:
Applications featuring the following are strongly encouraged:
A complete description of the application process and funding requirements for this program can be found in the RFA, with additional details in the ATIP Program FAQ.
PLEASE NOTE: If selected for funding, applicants whose pilots involve human subject's research or vertebrate animal studies must first obtain the appropriate regulatory approvals, including submission of a Request for Prior Approval to NCATS, before being permitted to access their grant and begin working. The funding period will not be extended to accommodate delays in securing any required approvals. The ICTR Research Navigators will provide guidance and support to teams throughout this process. Please see Appendix I: Regulatory Requirements/Approvals section of this RFA for additional information.
Application Deadline: 11:59 pm, Monday, December
Boost and Propel are clinical research grants
that award Clinical
Research Unit (CRU) services, including research space, overnight
beds, phlebotomy, specialized research nursing, and CRU-based imaging
(i.e. DXA, CV core) to investigators, based on scientific merit. Grants
are for one year with possible renewal based on study progress and achieving
BOOST awards are for junior investigators, first-time
R01 awardees, K awardees, and KL2 scholars to generate pilot data for
a larger grant submission or to supplement research funds for the K
PROPEL awards are intended for established investigators
who are performing early stage clinical trials, deep phenotyping studies,
or studies that address Maryland health priorities and can augment resources
of a funded project or provide resources for small pilot and feasibility
All investigators must submit an application to
a Johns Hopkins Institutional Review Board (IRB) before beginning the
award application. Review the Request
for Applications and link
to online form. Also consult Boost
and Propel Award Information and Frequently
The application deadline is Monday, December
21, 2020 by 11:59 pm. Any Johns Hopkins University faculty member
interested in funding for a new or ongoing clinical research project
is eligible to apply.
No application deadline
The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.
The ability to image alpha-synuclein deposition
in the brain would be a game-changing achievement for the Parkinson's
disease (PD) field. The accumulation of aggregated alpha-synuclein is
a pathological hallmark of PD and a priority target for drug development
given its hypothesized contribution to neurodegeneration. In vivo imaging
of alpha-synuclein pathology could be useful as a biomarker of the presence
of disease and disease progression and as a pharmacodynamic tool for
drug development. With this prize, the Foundation seeks to attract research
teams and accelerate momentum to speed the development of such a tracer.
Contestants: Anyone is eligible for
the prize who agrees to all contest rules. Contestants may be MJFF funded
or not and can be from either academia or industry.
Criteria for winning: The winning contestant
must demonstrate that the radiotracer binds with relatively high selectivity
to alpha-synuclein according to pre-specified criteria and must demonstrate
proof-of-concept in human subjects, including people with Parkinson's
disease and/or another synucleinopathy. See below for more details on
Timeline: There is no deadline
for submissions. The $2 million award will be issued to the first
contestant who submits compelling evidence of a viable selective tracer
and agrees to its widespread use. If no award is given by mid-2018,
The Michael J. Fox Foundation will evaluate the state of the field and
utility of such a prize.